UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
Form 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 and Rule 13a-17 or 15d-17 thereunder
MAXICARE HEALTH PLANS, INC.
-----------------------------------------------------------------
(Exact name of issuer as specified in charter)
1149 South Broadway Street, Los Angeles, CA 90015
-----------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (213) 765-2000
-----------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the
number of shares outstanding:
1. Title of security Common Stock
-------------------------------------------
2. Number of shares outstanding before the change 10,862,945
--------------
3. Number of shares outstanding after the change 11,506,756
--------------
4. Effective date of change February 23, 1995
------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of
stock for treasury, etc.) Conversion and options exercised
-----------------------------------
1 of 2
<PAGE>
Give brief description of transaction 221,0000 shares of
------------------------
Series A Cumulative Convertible Preferred Stock were converted
--------------------------------------------------------------
into 608,811 shares of Common Stock and options to purchase
--------------------------------------------------------------
35,000 shares were exercised.
--------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
----------------------------------------
2. Name after change
-------------------------------------------
3. Effective date of charter amendment changing name
-----------
4. Date of shareholder approval of change, if required
---------
Date February 24, 1995 /s/ EUGENE L. FROELICH
----------------- -----------------------------
Eugene L. Froelich
Chief Financial Officer and
Executive Vice President -
Finance and Administration
2 of 2
